Skip to main content
Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
44.24
-0.90 (-1.98%)
Nov 12, 2026, 2:26 PM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Revenue
7.06B6.82B5.99B
Cardiovascular Revenue
14.01B13.25B10.76B
Revenue (Other)
-2.00M--1.00M
Revenue (Total)
21.07B20.07B16.75B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
U.S Revenue
13.40B12.86B10.21B
Europe, Middle East and Africa Revenue
3.63B3.45B3.23B
Asia-Pacific Revenue
3.27B3.08B2.69B
Latin America and Canada Revenue
773.00M678.00M624.00M
Revenue (Other)
-1.00M-1.00M
Revenue (Total)
21.07B20.07B16.75B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
MedSurg Organic Revenue Growth
6.70%7.50%
Cardiovascular Organic Revenue Growth
20.80%21.90%
Total Organic Revenue Growth
15.80%16.40%